ProMIS Neurosciences Inc PMN

RE:RE:.12

[Actuarial]

The science itself is great but the management team sucks. If PMN has unlimited resources, they can do whatever they want. In reality, PMN don't have enough cash in the bank to complete even one small program. At the same time, the management team still getting paid well at the cost of shareholders. Financing at .10 won't help the company go further. Make a deal with big pharm or PMN would die quickly.

M101 wrote: Could happen, not a stretch at all.  We could still see financing at .10 and we could be bought out at .03 if not bankrupted, forced to sell the IP or return it to universities.  Gene and Elliot still think they can extract over $1000 each per day with no progress shown on any front. Apparently they think somehow they are above or we are immune to the kleptocracy happening in Washington, or that big pharma will set them up personally for life when they sell out.  I wish I did not have to feel that Covid19 was good luck for us but sadly that is the case.  Sadly it is Cashman and his public sector academic connections alone which have thrown us a lifeline while our conductor and lead violin play on, and the deck chairs quietly slip away.   
https://www.theguardian.com/business/2020/apr/22/top-economist-us-coronavirus-response-like-third-world-country-joseph-stiglitz-donald-trump